Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-000189
Filing Date
2025-01-08
Accepted
2025-01-08 16:23:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5616
  Complete submission text file 0001950047-25-000189.txt   7109
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Subject) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37478 | Film No.: 25518807
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address NATERA, INC. 13011 MCCALLEN PASS, BLDG A, STE 100 AUSTIN TX 78753
Business Address
RABINOWITZ DANIEL (Reporting) CIK: 0001857843 (see all company filings)

Type: 144